• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用全血细胞计数和分类参数诊断慢性髓系白血病的简单筛查方法。

A simple screening method for the diagnosis of chronic myeloid leukemia using the parameters of a complete blood count and differentials.

机构信息

Clinical Laboratory, Tokai University Hospital, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.

Department of Laboratory Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan; Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

出版信息

Clin Chim Acta. 2019 Feb;489:249-253. doi: 10.1016/j.cca.2018.08.038. Epub 2018 Aug 27.

DOI:10.1016/j.cca.2018.08.038
PMID:30165034
Abstract

BACKGROUND

This study aimed to develop a simple and inexpensive method using the complete blood count (CBC) and differentials to screen for chronic myeloid leukemia (CML).

METHODS

The receiver operating characteristic (ROC) curves of each CBC parameter, differential and the neutrophil alkaline phosphatase (NAP) score using CML and non-CML cases were generated to determine effective cut-off values. They were applied to the review of randomly-selected 45,608 samples for validation.

RESULTS

The leukocyte count showed the highest area under the ROC curve (AUC) value (0.909) among the CBC parameters. In the absolute counts of differentials, the AUC was the highest in basophils (0.982), followed by immature granulocytes (IGs) (0.975), which had cut-off values of 0.43 × 10/L and 0.46 × 10/L, respectively. The AUC of the NAP score was 0.963 at a cut-off value 122. In the validation, the absolute basophil counts were elevated in 280 samples from 96 cases, including 22 CML cases. In contrast, the absolute IG counts were elevated in 1310 samples from 516 cases, including only 17 CML cases. Three newly-diagnosed CML cases whose data were analyzed sequentially at the CML onset consistently met the basophil criteria before the IG criteria.

CONCLUSIONS

The absolute basophil count is effective for screening for CML.

摘要

背景

本研究旨在开发一种使用全血细胞计数(CBC)和分类计数来筛查慢性髓系白血病(CML)的简单且廉价的方法。

方法

生成了每个 CBC 参数、分类计数和中性粒细胞碱性磷酸酶(NAP)评分的受试者工作特征(ROC)曲线,以确定有效的临界值。将它们应用于随机选择的 45608 个样本进行验证。

结果

白细胞计数在 CBC 参数中显示出最高的 ROC 曲线下面积(AUC)值(0.909)。在分类计数的绝对值中,嗜碱性粒细胞的 AUC 最高(0.982),其次是未成熟粒细胞(IG)(0.975),其临界值分别为 0.43×10/L 和 0.46×10/L。NAP 评分的 AUC 值为 122 时为 0.963。在验证中,96 例中有 280 例(280 例)样本的绝对嗜碱性粒细胞计数升高,其中包括 22 例 CML 病例。相比之下,516 例中有 1310 例(1310 例)样本的绝对 IG 计数升高,其中仅 17 例 CML 病例。对 CML 发病时依次进行数据分析的 3 例新诊断 CML 病例,在 IG 标准之前均符合嗜碱性粒细胞标准。

结论

绝对嗜碱性粒细胞计数对筛查 CML 有效。

相似文献

1
A simple screening method for the diagnosis of chronic myeloid leukemia using the parameters of a complete blood count and differentials.一种使用全血细胞计数和分类参数诊断慢性髓系白血病的简单筛查方法。
Clin Chim Acta. 2019 Feb;489:249-253. doi: 10.1016/j.cca.2018.08.038. Epub 2018 Aug 27.
2
Predicting chronic leukaemias from assessment of complete peripheral blood counts.通过全血细胞计数评估预测慢性白血病
J Int Med Res. 2006 Nov-Dec;34(6):640-7. doi: 10.1177/147323000603400609.
3
Unique characteristics of leukocyte volume, conductivity and scatter in chronic myeloid leukemia.慢性髓性白血病中白细胞体积、传导性和散射的独特特征。
Biomed J. 2019 Apr;42(2):93-98. doi: 10.1016/j.bj.2018.12.004. Epub 2019 May 6.
4
[The prognostic significance of the differential blood count in patients with chronic myeloid leukemia].[慢性髓性白血病患者血细胞计数差异的预后意义]
Med Klin (Munich). 1989 Aug 15;84(8):373-7.
5
[Chronic myeloid leukemia beginning as thrombocythemia. Analysis of 5 cases].
Sangre (Barc). 1992 Feb;37(1):1-3.
6
Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?重新审视BCR-ABL蛋白流式细胞术免疫微珠检测:对慢性髓性白血病的诊断和监测效力如何?
Int J Lab Hematol. 2015 Oct;37(5):723-8. doi: 10.1111/ijlh.12394. Epub 2015 Jun 9.
7
Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.使用嗜碱性粒细胞特异性单克隆抗体2D7对骨髓增殖性疾病中的骨髓嗜碱性粒细胞进行计数和免疫组织化学特征分析。
J Clin Pathol. 2006 Apr;59(4):396-402. doi: 10.1136/jcp.2005.029215. Epub 2006 Feb 3.
8
Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.慢性髓性白血病的白血病前期:7 例病例的形态学和免疫组织化学特征。
Ann Diagn Pathol. 2016 Apr;21:53-8. doi: 10.1016/j.anndiagpath.2015.12.004. Epub 2016 Feb 6.
9
Factors Affecting Early Molecular Response in Chronic Myeloid Leukemia.影响慢性髓性白血病早期分子反应的因素
Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S114-9. doi: 10.1016/j.clml.2015.03.014.
10
P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?P190BCR-ABL 慢性髓性白血病:与慢性粒单核细胞白血病的缺失环节?
Leukemia. 1994 Jan;8(1):208-11.

引用本文的文献

1
Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometry.使用幽灵流式细胞术通过人工智能驱动的慢性髓性白血病细胞无标记检测
Sci Rep. 2025 Jul 1;15(1):21046. doi: 10.1038/s41598-025-06664-9.
2
Bilosomes and Niosomes for Enhanced Intestinal Absorption and In Vivo Efficacy of Cytarabine in Treatment of Acute Myeloid Leukemia.用于增强阿糖胞苷肠道吸收及体内治疗急性髓系白血病疗效的双分子层脂质体和非离子表面活性剂泡囊
Pharmaceuticals (Basel). 2024 Nov 23;17(12):1572. doi: 10.3390/ph17121572.
3
Advancements in leukemia management: Bridging diagnosis, prognosis and nanotechnology (Review).
白血病管理的进展:连接诊断、预后和纳米技术(综述)。
Int J Oncol. 2024 Dec;65(6). doi: 10.3892/ijo.2024.5700. Epub 2024 Oct 4.
4
Disease Burden, Risk Factors, and Trends of Leukaemia: A Global Analysis.白血病的疾病负担、风险因素及趋势:一项全球分析。
Front Oncol. 2022 Jul 22;12:904292. doi: 10.3389/fonc.2022.904292. eCollection 2022.
5
Anthropometric indices, blood pressure, and lipid profile status among women using progestin-only contraceptives: comparative cross-sectional study.单纯孕激素避孕药使用者的人体测量指数、血压和血脂状况:比较横断面研究。
BMC Womens Health. 2021 Jan 23;21(1):34. doi: 10.1186/s12905-021-01178-8.